首页 > 最新文献

Regular and Young Investigator Award Abstracts最新文献

英文 中文
113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy 113揭示头颈部鳞状细胞癌(HNSCC)的暗免疫肽:与通用癌症疫苗、免疫监测和TIL治疗的相关性
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0113
N. Iwamoto, T. Shimada, T. Moudgil, Ryan Meng, Tanisha Christie, Alexander C. Dowell, R. Leidner, B. Bell, William L. Redmond, E. Tran, Hong-Ming Hu, T. Hilton, B. Piening, Y. Koguchi, B. Fox
Background Discoveries of the last two years have initiated a renaissance in our understanding of the targets T cells recog-nize on cancer cells. Identification of HLA-presented non-can-onical or cryptic peptides that are non-mutated and have high interpatient sharing in AML [PMID: 33740418], coupled with their absence from the thymus, led them to be designated as alternative neoantigens with potential for being universal cancer vaccines [PMID: 33852826]. These cryptic genes, in some cases, appear to play a role in promoting malignancy, further strengthening the rationale for their identification and use as targets for immunotherapy. Our group seeks to identify the Dark Immunopeptidome of HNSCC. Over the last several months we have swithed from exome-capture RNA-Seq, which fails to detect non-canonical gene sequences, to ribo-Seq, which can capture these cryptic transcripts.
过去两年的发现使我们对T细胞识别癌细胞的目标的理解有了新的认识。hla呈现的非典型或隐型肽的鉴定是非突变的,在AML中具有高度的患者共享性[PMID: 33740418],加上它们不存在于胸腺中,使它们被指定为替代的新抗原,有可能成为通用的癌症疫苗[PMID: 33852826]。在某些情况下,这些隐基因似乎在促进恶性肿瘤中发挥作用,进一步加强了它们的识别和用作免疫治疗靶点的理由。本小组试图鉴定HNSCC的暗免疫肽。在过去的几个月里,我们已经从外显子组捕获RNA-Seq(无法检测非典型基因序列)转向了核糖- seq(可以捕获这些隐式转录本)。
{"title":"113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy","authors":"N. Iwamoto, T. Shimada, T. Moudgil, Ryan Meng, Tanisha Christie, Alexander C. Dowell, R. Leidner, B. Bell, William L. Redmond, E. Tran, Hong-Ming Hu, T. Hilton, B. Piening, Y. Koguchi, B. Fox","doi":"10.1136/jitc-2022-sitc2022.0113","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0113","url":null,"abstract":"Background Discoveries of the last two years have initiated a renaissance in our understanding of the targets T cells recog-nize on cancer cells. Identification of HLA-presented non-can-onical or cryptic peptides that are non-mutated and have high interpatient sharing in AML [PMID: 33740418], coupled with their absence from the thymus, led them to be designated as alternative neoantigens with potential for being universal cancer vaccines [PMID: 33852826]. These cryptic genes, in some cases, appear to play a role in promoting malignancy, further strengthening the rationale for their identification and use as targets for immunotherapy. Our group seeks to identify the Dark Immunopeptidome of HNSCC. Over the last several months we have swithed from exome-capture RNA-Seq, which fails to detect non-canonical gene sequences, to ribo-Seq, which can capture these cryptic transcripts.","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"137 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116605415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
799 Real-world use of pembrolizumab combination regimens in first-line recurrent/metastatic head and neck squamous cell carcinoma 799派姆单抗联合方案在一线复发/转移性头颈部鳞状细胞癌中的实际应用
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0799
C. Black, Liya Wang, K. Ramakrishnan, D. Goto
799 Table 1 Real-World Time on Treatment Results http://dx.doi.org/10.1136/jitc-2022-SITC2022.0799 Abstracts A832 J Immunother Cancer 2022;10(Suppl 2):A1–A1603 on Jne 2, 2023 by gest. P rocted by coright. http/jitc.bm jcom / J Im m unther C acer: frst pulished as 10.11jitc-2022-S IT C 20.0799 on 7 N ovem er 222. D ow nladed fom
799表1治疗结果的真实世界时间http://dx.doi.org/10.1136/jitc-2022-SITC2022.0799摘要A832 J Immunother Cancer 2022;10(增刊2):A1-A1603, 2023年6月2日。P由赖特保护。http /宗旨。jj.com / jim m unther C acer:首次发布为10.11 jtc -2022- sit C 20.0799,发布于7月22日。我们从
{"title":"799 Real-world use of pembrolizumab combination regimens in first-line recurrent/metastatic head and neck squamous cell carcinoma","authors":"C. Black, Liya Wang, K. Ramakrishnan, D. Goto","doi":"10.1136/jitc-2022-sitc2022.0799","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0799","url":null,"abstract":"799 Table 1 Real-World Time on Treatment Results http://dx.doi.org/10.1136/jitc-2022-SITC2022.0799 Abstracts A832 J Immunother Cancer 2022;10(Suppl 2):A1–A1603 on Jne 2, 2023 by gest. P rocted by coright. http/jitc.bm jcom / J Im m unther C acer: frst pulished as 10.11jitc-2022-S IT C 20.0799 on 7 N ovem er 222. D ow nladed fom","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"209 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116744588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1309 Differential microbial enrichment is associated with oral cancer and perineural invasion 1309 .不同的微生物富集与口腔癌和神经周围浸润有关
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.1309
August Culbert, A. Chow, Raad Gharaibah, Naseer Sangwan, M. Dwidar, Rachel C. Newsome, Jin Dai, Siming Ma, Kristianna M Fredenburg, E. Yilmaz, S. Koyfman, Daniel McGrail, J. Ku, C. Jobin, N. Silver
Background Advanced oral cavity squamous cell carcinoma (OSCC) is an aggressive disease, with 5-year overall survival rates below 50%. 1 While smoking and alcohol are the most established risk factors, there is growing evidence implicating the role of the oral microbiome in promoting immunosuppres-sive states in OSCC. 2-6 The objective of this study was to evaluate the taxonomic profile of oral bacteria in advanced OSCC patients and correlate with clinicopathologic features. approved this study of patients diagnosed with treated from Samples were taken from tumor and paired adjacent normal tissues at the time of surgery and snap frozen. Demographics, clinical and pathologic information was collected. DNA from 51 samples was isolated and 16s rRNA gene sequencing was performed after PCR amplification of the V1-V3 regions of the 16s rRNA gene for paired samples. 16S rRNA sequences were processed using DADA2, implemented in QIIME2 package, and taxonomic assignments were made using RDA classifier using the Human Oral Microbiome Data-base V15.22 as the reference database. Sequencing reads proc-essing, denoising, dereplicating, chimeras filtering, and amplicon sequence variants (ASVs) generation was done using DADA2. The association between clinicopathological factors and bacterial profiles was evaluated using R Software.
背景:晚期口腔鳞状细胞癌(OSCC)是一种侵袭性疾病,5年总生存率低于50%。虽然吸烟和酒精是最确定的危险因素,但越来越多的证据表明口腔微生物组在促进OSCC免疫抑制状态中的作用。2-6本研究的目的是评估晚期OSCC患者口腔细菌的分类特征及其与临床病理特征的相关性。在手术和快速冷冻时,从肿瘤和配对的邻近正常组织中提取样本。收集人口统计学、临床和病理资料。从51份样本中分离DNA,对配对样本进行16s rRNA基因V1-V3区PCR扩增后,进行16s rRNA基因测序。16S rRNA序列使用DADA2处理,QIIME2软件包实现,以Human Oral Microbiome database V15.22作为参考数据库,使用RDA分类器进行分类。使用DADA2进行测序读取处理、去噪、去复制、嵌合体过滤和扩增子序列变异(asv)的生成。使用R软件评估临床病理因素与细菌谱之间的关系。
{"title":"1309 Differential microbial enrichment is associated with oral cancer and perineural invasion","authors":"August Culbert, A. Chow, Raad Gharaibah, Naseer Sangwan, M. Dwidar, Rachel C. Newsome, Jin Dai, Siming Ma, Kristianna M Fredenburg, E. Yilmaz, S. Koyfman, Daniel McGrail, J. Ku, C. Jobin, N. Silver","doi":"10.1136/jitc-2022-sitc2022.1309","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.1309","url":null,"abstract":"Background Advanced oral cavity squamous cell carcinoma (OSCC) is an aggressive disease, with 5-year overall survival rates below 50%. 1 While smoking and alcohol are the most established risk factors, there is growing evidence implicating the role of the oral microbiome in promoting immunosuppres-sive states in OSCC. 2-6 The objective of this study was to evaluate the taxonomic profile of oral bacteria in advanced OSCC patients and correlate with clinicopathologic features. approved this study of patients diagnosed with treated from Samples were taken from tumor and paired adjacent normal tissues at the time of surgery and snap frozen. Demographics, clinical and pathologic information was collected. DNA from 51 samples was isolated and 16s rRNA gene sequencing was performed after PCR amplification of the V1-V3 regions of the 16s rRNA gene for paired samples. 16S rRNA sequences were processed using DADA2, implemented in QIIME2 package, and taxonomic assignments were made using RDA classifier using the Human Oral Microbiome Data-base V15.22 as the reference database. Sequencing reads proc-essing, denoising, dereplicating, chimeras filtering, and amplicon sequence variants (ASVs) generation was done using DADA2. The association between clinicopathological factors and bacterial profiles was evaluated using R Software.","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117019902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
81 T cell stimulation assay and immunoassays comparison for soluble cytokines profiling in drug discovery T细胞刺激试验和免疫试验在药物发现中可溶性细胞因子分析的比较
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0081
C. Lefranc, Nicole Meritet, K. Berthelot, O. Flamand, J. Baudhuin, Jack Pollard, L. Canard, A. Biancotto
{"title":"81 T cell stimulation assay and immunoassays comparison for soluble cytokines profiling in drug discovery","authors":"C. Lefranc, Nicole Meritet, K. Berthelot, O. Flamand, J. Baudhuin, Jack Pollard, L. Canard, A. Biancotto","doi":"10.1136/jitc-2022-sitc2022.0081","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0081","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129505308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
20 Development of VISTA-centric tumor immunophenotyping as a novel approach for identification of potential biomarkers for anti-VISTA therapy 以vista为中心的肿瘤免疫分型作为一种鉴定抗vista治疗潜在生物标志物的新方法的发展
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0020
A. Ugolkov, R. Roemeling, Alexander Martin, R. Martell
{"title":"20 Development of VISTA-centric tumor immunophenotyping as a novel approach for identification of potential biomarkers for anti-VISTA therapy","authors":"A. Ugolkov, R. Roemeling, Alexander Martin, R. Martell","doi":"10.1136/jitc-2022-sitc2022.0020","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0020","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129766234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
702 Tertiary lymphoid structures (TLS) observed in non-small cell lung cancer (NSCLC) tumors treated with pulsed electric fields 脉冲电场治疗非小细胞肺癌(NSCLC)肿瘤观察到三级淋巴样结构(TLS)
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0702
J. Iding, Paul VanderLaan, Marcelo Jimenez, J. F. García-Hierro, J. F. Aldeyturriaga, Erik H. F. M. Heijden, C. Ng, R. Lau, Maria Ludeña, Rafael Carías, O. Cedeño, Alicia Moreno-Gonzalez, B. Hatton, W. Krimsky
{"title":"702 Tertiary lymphoid structures (TLS) observed in non-small cell lung cancer (NSCLC) tumors treated with pulsed electric fields","authors":"J. Iding, Paul VanderLaan, Marcelo Jimenez, J. F. García-Hierro, J. F. Aldeyturriaga, Erik H. F. M. Heijden, C. Ng, R. Lau, Maria Ludeña, Rafael Carías, O. Cedeño, Alicia Moreno-Gonzalez, B. Hatton, W. Krimsky","doi":"10.1136/jitc-2022-sitc2022.0702","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0702","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129882443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
903 APR-246 induces an increase in tumor immunogenicity in a p53 independent manner 903 APR-246以p53独立的方式诱导肿瘤免疫原性的增加
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0903
D. Venkatesh, J. Michels, Cailin Lu, S. Budhu, Mariam M. George, O. Ouerfelli, L. Abrahmsén, R. Zappasodi, J. Wolchok, T. Merghoub
{"title":"903 APR-246 induces an increase in tumor immunogenicity in a p53 independent manner","authors":"D. Venkatesh, J. Michels, Cailin Lu, S. Budhu, Mariam M. George, O. Ouerfelli, L. Abrahmsén, R. Zappasodi, J. Wolchok, T. Merghoub","doi":"10.1136/jitc-2022-sitc2022.0903","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0903","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128572150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1015 Natural killer cells in immunotherapy-induced MHC-I tumor escape 1015免疫治疗诱导的MHC-I肿瘤逃逸中的自然杀伤细胞
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.1015
E. Miao, Jennifer Poursine‐Laurent, K. Sheehan, R. Schreiber, W. Yokoyama, S. Piersma
{"title":"1015 Natural killer cells in immunotherapy-induced MHC-I tumor escape","authors":"E. Miao, Jennifer Poursine‐Laurent, K. Sheehan, R. Schreiber, W. Yokoyama, S. Piersma","doi":"10.1136/jitc-2022-sitc2022.1015","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.1015","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"122 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128627437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
999 Investigating the immunomodulatory role of innate lymphoid cells in epithelial ovarian carcinoma 研究先天淋巴样细胞在上皮性卵巢癌中的免疫调节作用
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0999
D. Chung, K. Warner, Jehan Vakharia, SeongJun Han, M. Ghaedi, Carlos R. Garcia-Batres, N. Jacquelot, Azin Sayad, Sarah Ferguson, P. Ohashi
{"title":"999 Investigating the immunomodulatory role of innate lymphoid cells in epithelial ovarian carcinoma","authors":"D. Chung, K. Warner, Jehan Vakharia, SeongJun Han, M. Ghaedi, Carlos R. Garcia-Batres, N. Jacquelot, Azin Sayad, Sarah Ferguson, P. Ohashi","doi":"10.1136/jitc-2022-sitc2022.0999","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0999","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128667314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
977 Highly cytotoxic resilient CD8+T cells avoid exhaustion by lowering ROS through ME1 upregulation 977高细胞毒性韧性CD8+T细胞通过上调ME1降低ROS来避免衰竭
Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0977
Joanina K. Gicobi, Haidong Dong, Cindy Liu
{"title":"977 Highly cytotoxic resilient CD8+T cells avoid exhaustion by lowering ROS through ME1 upregulation","authors":"Joanina K. Gicobi, Haidong Dong, Cindy Liu","doi":"10.1136/jitc-2022-sitc2022.0977","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0977","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128711854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Regular and Young Investigator Award Abstracts
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1